TL Start Date
Wednesday, August 19, 2015
TL End Date
Wednesday, August 19, 2015
TL Display Date
2015
TL Background
#696969
TL Text
In a controversial decision (and with opposition from the New View Campaign), the US FDA approved flibanserin to treat hyposexual desire disorder (HSDD) in premenopausal women.